VIEWPOINT MOLECULAR TARGETING INC

Overview

VIEWPOINT MOLECULAR TARGETING INC is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering [203PB]VMT-A-NET SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY AGENT; [212Pb]VMT-A-NET.

API / Drug Master Files

VIEWPOINT MOLECULAR TARGETING INC holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• [212Pb]VMT-A-NETActive2022-10-17
• [203PB]VMT-A-NET SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY AGENTActive2022-05-02

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to VIEWPOINT MOLECULAR TARGETING INC in our records. PharmaTek screens the full directory against live FDA enforcement data.